MyAverix Finance
ST · Healthcare
Mendus AB (publ) (IMMU)
Biotechnology
Mendus AB (publ) (IMMU) is listed on ST in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for IMMU
Mendus AB (publ) (IMMU) — FAQ
What is IMMU's P/E ratio?
The price-to-earnings (P/E) ratio for Mendus AB (publ) (IMMU) is 25.00 (data as of 2026-05-24).
Does Mendus AB (publ) pay a dividend?
Dividend yield is not available in the current snapshot for Mendus AB (publ) (IMMU). Check the MyAverix Finance app for the latest dividend data.
What sector is Mendus AB (publ) in?
Mendus AB (publ) (IMMU) is classified in the Healthcare sector (Biotechnology industry).
What exchange is IMMU listed on?
IMMU is listed on ST.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.